Insider Trading March 18, 2026

National Presto Industries CFO Sells 500 Shares Worth $70,077

Form 4 shows sale came from long-held 401(k) holdings; post-sale direct and indirect stakes remain modest

By Leila Farooq NPK
National Presto Industries CFO Sells 500 Shares Worth $70,077
NPK

David J. Peuse, chief financial officer and treasurer of National Presto Industries Inc (NPK), sold 500 shares on March 17, 2026, for $140.155 per share, generating $70,077. The transaction, disclosed in an SEC Form 4, involved shares acquired through the company 401(k) plan between July 31, 2000 and March 31, 2020. After the sale, Peuse holds 1,669 shares directly and 308 shares indirectly via a 401(k) plan. InvestingPro analysis cited in the filing notes NPK appears slightly undervalued and refers investors to a Pro Research Report for deeper data.

Key Points

  • CFO David J. Peuse sold 500 shares of National Presto Industries on March 17, 2026, at $140.155 per share, totaling $70,077.
  • The sold shares were acquired through the company 401(k) plan between July 31, 2000 and March 31, 2020; the Form 4 was filed with the SEC to disclose the transaction.
  • After the sale, Peuse directly holds 1,669 shares and indirectly holds 308 shares via a 401(k); the filing includes an InvestingPro note that NPK appears slightly undervalued.

Transaction details

David J. Peuse, who occupies the roles of chief financial officer and treasurer at National Presto Industries Inc (NYSE: NPK), executed a sale of 500 shares of company stock on March 17, 2026. The shares traded at $140.155 apiece, producing gross proceeds of $70,077.

Source of shares and regulatory disclosure

The disposition was recorded on a Form 4 filed with the Securities and Exchange Commission. The filing specifies that the shares sold were acquired over time through the company-sponsored 401(k) plan, with acquisition dates ranging from July 31, 2000, to March 31, 2020.

Holdings following the sale

Following the March 17 transaction, Peuse is reported to directly own 1,669 shares of National Presto Industries. In addition, he holds 308 shares indirectly through a 401(k) plan.

Analyst note included in the filing

The filing references InvestingPro analysis, which indicates that NPK remains slightly undervalued. The notice also points investors to a comprehensive Pro Research Report for expanded analysis and data synthesis on the company.

Context and limits of the disclosure

The Form 4 provides a clear record of this specific trade and the provenance of the shares sold, but it does not state a reason for the sale or indicate any change in company strategy or financial outlook. The information is limited to the mechanics of the trade, the acquisition window for the disposed shares, and the CFO's remaining direct and indirect holdings.


Summary

National Presto Industries' CFO and treasurer sold 500 shares on March 17, 2026, at $140.155 per share for total proceeds of $70,077. The sale involved share lots obtained through a 401(k) plan between July 31, 2000 and March 31, 2020. Post-transaction holdings are 1,669 shares directly and 308 shares indirectly via a 401(k). An InvestingPro note in the filing states that NPK appears slightly undervalued and offers a Pro Research Report for further detail.

Risks

  • The Form 4 documents this single transaction but does not provide the motivation behind the sale, leaving uncertainty about intent - this affects investor interpretation and market signaling.
  • The filing is limited to holdings and transactional mechanics; the absence of broader disclosure means the trade provides only a narrow data point for assessing insider sentiment.
  • Because the sale represents a modest dollar amount relative to broader market capitalization, the market impact is likely limited, which may constrain the utility of this disclosure for short-term price inference.

More from Insider Trading

Foxx Development CEO Disposes of $30,436 in Stock; Board Addition and Meeting Clarification Also Filed Mar 18, 2026 IRadimed CEO Disposes $762,970 in Stock as Shares Trade Near Yearly Peak Mar 18, 2026 Harvard Bioscience Director Increases Stake with $48,700 Purchase Mar 18, 2026 Babcock & Wilcox CEO Increases Stake With $106,015 Market Purchase; Earlier Option Exercise and RSU Grant Expanded Holdings Mar 18, 2026 Babcock & Wilcox CFO Makes Purchase, Exercises RSUs as Company Posts Q4 Beat Mar 18, 2026